Fundamental Analysis of CHINA JO-JO DRUGSTORES HOLDI(NASDAQ:CJJD) stock

Fundamental Rating

Overall CJJD gets a fundamental rating of 1 out of 10. We evaluated CJJD against 40 industry peers in the Consumer Staples Distribution & Retail industry. CJJD may be in some trouble as it scores bad on both profitability and health. CJJD has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

CJJD had negative earnings in the past year.

In the past year CJJD has reported a negative cash flow from operations.

CJJD had negative earnings in each of the past 5 years.

CJJD had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of CJJD (-22.27%) is worse than 82.50% of its industry peers.

Looking at the Return On Equity, with a value of -111.73%, CJJD is doing worse than 87.50% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-22.27%
ROE	-111.73%
ROIC	N/A

ROA(3y)-11.27%

ROA(5y)-8.18%

ROE(3y)-54.01%

ROE(5y)-39.02%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of CJJD (23.05%) is comparable to the rest of the industry.

In the last couple of years the Gross Margin of CJJD has grown nicely.

The Profit Margin and Operating Margin are not available for CJJD so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	23.05%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.97%

GM growth 5Y1.96%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CJJD does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for CJJD has been increased compared to 1 year ago.

The number of shares outstanding for CJJD has been increased compared to 5 years ago.

The debt/assets ratio for CJJD has been reduced compared to a year ago.

2.2 Solvency

CJJD has an Altman-Z score of -0.06. This is a bad value and indicates that CJJD is not financially healthy and even has some risk of bankruptcy.

CJJD has a Altman-Z score of -0.06. This is amonst the worse of the industry: CJJD underperforms 87.50% of its industry peers.

CJJD has a Debt/Equity ratio of 1.30. This is a high value indicating a heavy dependency on external financing.

CJJD's Debt to Equity ratio of 1.30 is on the low side compared to the rest of the industry. CJJD is outperformed by 82.50% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.3
Debt/FCF	N/A
Altman-Z	-0.06

ROIC/WACCN/A

WACC1.85%

2.3 Liquidity

A Current Ratio of 1.00 indicates that CJJD should not have too much problems paying its short term obligations.

CJJD has a Current ratio of 1.00. This is in the lower half of the industry: CJJD underperforms 62.50% of its industry peers.

A Quick Ratio of 0.72 indicates that CJJD may have some problems paying its short term obligations.

CJJD's Quick ratio of 0.72 is in line compared to the rest of the industry. CJJD outperforms 55.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1
Quick Ratio	0.72

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CJJD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -125.00%.

The Revenue has decreased by -9.49% in the past year.

The Revenue has been growing by 9.14% on average over the past years. This is quite good.

EPS 1Y (TTM)-125%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-494.58%

Revenue 1Y (TTM)-9.49%

Revenue growth 3Y8.25%

Revenue growth 5Y9.14%

Revenue growth Q2Q8.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CJJD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CJJD!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CHINA JO-JO DRUGSTORES HOLDI

NASDAQ:CJJD (5/17/2024, 7:00:00 PM)

2.9889

+0.44 (+17.21%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupConsumer Staples Distribution & Retail

GICS IndustryConsumer Staples Distribution & Retail

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap13.96M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-22.27%
ROE	-111.73%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	23.05%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.57

Health

		Industry Rank	Sector Rank
Debt/Equity	1.3
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1
Quick Ratio	0.72
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-125%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-9.49%

Revenue growth 3Y8.25%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

CHINA JO-JO DRUGSTORES HOLDI (CJJD)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens